KALAMAZOO ? The next Kalamazoo Venture Tuesday November 1 will focus on Michigan Success Stories – Esperion Therapeutics and Afmedica, Inc. – Where are they now?
The moderator will be Mina Sooch, Apjohn Ventures, General Partner and Afmedica, co-founder. Panelists will include:
Roger Newton, co-founder, Esperion Therapeutics
Michael Pape, co-founder, Esperion Therapeutics
Charlie Bisgaier, co-founder, Esperion Therapeutics
Eli Thomssen, co-founder & CBO, Afmedica, Inc. and CEO & founder, Axenic Dental
Presenting companies include:
Holomics, Inc., a Michgan-based start-up company, proposes to develop a glucometer-based device that will rapidly detect the presence of Pseudomonas in fluids including blood.
Quantum Signal (QS) is an engineering company specializing in the development of advanced, innovative signal and image processing technologies.
ThreeFold Sensors, Inc. (TFS) brings a revolutionary new approach to molecular diagnostics that will powerfully extend the point of care market and open up the field of personalized medicine.
NeuRxus is a Michigan-based company formed to develop and commercialize small molecules and drug targets for central nervous system therapeutic indications such as Parkinson’s, Alzheimer’s disease and depression.
Axenic Dental, Inc. is a newly formed dental device company focused on developing a disposable high-speed dental handpiece to address an unmet market opportunity in the dental profession.
The meeting is scheduled for Nov. 1 from 9 am to noon at the Radisson Plaza Hotel in downtown Kalamazoo. The monthly event was held at the Southwest Michigan Innovation Center.
Gail Lindsey, who runs Kalamazoo Venture Tuesday for Southwest Michigan First, said with the holiday season approaching, SMF has decided to cancel the December Kalamazoo Venture Tuesday meeting.
For more information, click on SouthwestMichiganFirst.Com
